These drives reflect our commitment to community health, not just in February, but year-round—especially as we look ...
We are proud to invest in tools that elevate our standard of care and help more people live longer, healthier lives.”— ...
For most of the 20th century all women with breast cancer received similar treatment. Therapy has since become more individualized: breast cancers are now divided into subtypes and treated accordingly ...
UC San Francisco and Quest Diagnostics, the world's leading provider of diagnostic information services, have formed a collaboration to accelerate the translation of biomedical research into advanced ...
Quest Diagnostics Inc. DGX is investing in advanced diagnostics to deliver and scale innovative services that improve patient care and drive growth. Acquisitions remain a key growth driver for the ...
Bio-Techne, which makes proteins for biomedical and clinical researchers, will acquire Advanced Cell Diagnostics for $250 million in cash, with a potential $75 ...
Quest Diagnostics raised its full year 2025 guidance, with Samad providing, "Revenues are expected to be between $10.8 billion and $10.92 billion. Reported EPS is now expected to be in a range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results